Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07218445 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 25 words
    • Secondary endpoints: details revised at 14 of 14 entries
    • Site contact updated
  2. Eligibility criteria expanded, about 63 wordsv6
  3. Start date changed from estimate of Apr 2026 to Apr 8, 2026
    • Site contact updated
    v5
  4. Trial status: Active, Not Recruiting to Recruiting
    • Start date: Sep 16, 2025 to Apr 2026
    • Site details revised
    v4
  5. Secondary endpoints: 6 to 14v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,021 trials monitored
See 125 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.
Trial Details
NCT Number NCT07218445
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Obesity, Menopause Hot Flashes
Related terms Hot Flashes, Obesity
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov